Diagnostics is an integral part of medical decision-making -- aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare. Molecular diagnostics has a critical role in precision medicine approach, as it ensures safe and effective application of targeted therapeutics. A majority of the players in the global molecular diagnostics market offer products encompassing the kits and reagents, instruments, and software categories. Also, several diagnostics and pharmaceutical companies are working collaboratively to develop NGS, PCR, IHC, ISH, microarray, nucleic acid amplification-, or mass spectrometry-based molecular diagnostics for the applications in several disease indications in order to enable efficient diagnosis, treatment selection, dosage selection, and treatment monitoring. Applications of molecular diagnostics primarily include infectious diseases, cancer, genetic testing, and women’s health, among others.

Executive Summary 

Research Methodology 

1. Market Overview

2. Industry Analysis 

3. Market Dynamics 

4. Competitive Landscape

5. Automation in Biomanufacturing

6. Workflow and Products

7. Medical Application

8. End User

9. Regions

10. Markets - Competitive Benchmarking & Company Profiles